Glycosidase inhibitors
US11046712B2 · kind B2 · utility
11Cited by
12References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2019 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | May 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to compounds of formula (I) useful in the treatment of tauopathies and Alzheimer's disease wherein A, R, W, Q, n, and m are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.